These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35024360)

  • 1. QTc prolongation in patients with COVID-19: a retrospective chart review.
    Pornwattanakavee SP; Priksri W; Leelakanok N
    Transl Clin Pharmacol; 2021 Dec; 29(4):197-205. PubMed ID: 35024360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
    Diaz-Arocutipa C; Brañez-Condorena A; Hernandez AV
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):694-706. PubMed ID: 33772933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review.
    Tomaselli Muensterman E; Tisdale JE
    Pharmacotherapy; 2018 Aug; 38(8):813-821. PubMed ID: 29882591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: Results of a multicenter national survey.
    Haghjoo M; Golipra R; Kheirkhah J; Golabchi A; Shahabi J; Oni-Heris S; Sami R; Tajmirriahi M; Saravi M; Khatami M; Varnasseri M; Kiarsi M; Hejazi SF; Yousefzadeh Rahaghi M; Taherkhani M; Ashraf H; Keshmiri MS; Akbarzadeh MA; Bozorgi A; Mottaghizadeh F; Hedayat B; Heidarali M; Hajhossein Talasaz A
    Int J Clin Pract; 2021 Jul; 75(7):e14182. PubMed ID: 33759318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for QTc-prolongation: systematic review of the evidence.
    Vandael E; Vandenberk B; Vandenberghe J; Willems R; Foulon V
    Int J Clin Pharm; 2017 Feb; 39(1):16-25. PubMed ID: 28012118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
    O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
    JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients.
    Russo V; Carbone A; Mottola FF; Mocerino R; Verde R; Attena E; Verde N; Di Micco P; Nunziata L; Santelli F; Nigro G; Severino S
    Front Pharmacol; 2020; 11():582348. PubMed ID: 33132915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.
    Vieweg WV; Hasnain M; Hancox JC; Baranchuk A; Digby GC; Kogut C; Crouse EL; Koneru JN; Deshmukh A; Pandurangi AK
    Psychopharmacology (Berl); 2013 Aug; 228(4):515-24. PubMed ID: 23812796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
    Padilla S; Telenti G; Guillén L; García JA; García-Abellán J; Ding C; Mora A; García-Pachón E; Gutiérrez F; Masiá M;
    Int J Antimicrob Agents; 2020 Oct; 56(4):106142. PubMed ID: 32853675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.
    Hasnain M; Vieweg WV
    CNS Drugs; 2014 Oct; 28(10):887-920. PubMed ID: 25168784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.
    Tisdale JE
    Can Pharm J (Ott); 2016 May; 149(3):139-52. PubMed ID: 27212965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cases of drug-induced Torsade de Pointes: a review of Belgian cases in the EudraVigilance database.
    Vandael E; Vandenberk B; Vandenberghe J; Willems R; Foulon V
    Acta Clin Belg; 2017 Dec; 72(6):385-390. PubMed ID: 28335691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
    Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.
    Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced 'Torsade de Pointes' in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report.
    Semedo E; Kapel GF; van Opstal J; van Dessel PFHM
    Eur Heart J Case Rep; 2020 Oct; 4(FI1):1-5. PubMed ID: 33089050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives.
    Duan J; Tao J; Zhai M; Li C; Zhou N; Lv J; Wang L; Lin L; Bai R
    Oncotarget; 2018 May; 9(39):25738-25749. PubMed ID: 29876021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.